- 商品介绍
- 规格参数
- 包装参数
Application
Nisoldipine has been used:
- as a hit-antagonist to study its effects on oxytocin (OT)-induced myometrial Ca2+-mobilization and its potency to dampen uterine myometrial contractions
- as a calcium channel blocker to study its effects on cell viability in a human hepatic cancer HepG2 and rat renal epithelial NRK52E cell line
- as a component of the external IK1 recording solution to study the action potential in human pluripotent stem cell−derived cardiomyocytes (hiPS-CMs)
Biochem/physiol Actions
L-type (CaV1.2) calcium channel blocker; dihydropyridine-type calcium channel blocker with selectivity for smooth muscle (CaV1.2b) over cardiac muscle (CaV1.2a). Arterial vasodilator and antihypertensive agent.
Features and Benefits
This compound is featured on the Calcium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | yellow |
| solubility | DMSO: >10 mg/mL |
| originator | Bayer |
| storage temp. | room temp |
| SMILES string | COC(=O)C1=C(C)NC(C)=C(C1c2ccccc2[N+]([O-])=O)C(=O)OCC(C)C |
| InChI | 1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3 |
| InChI key | VKQFCGNPDRICFG-UHFFFAOYSA-N |
| Gene Information | human ... CACNA1C(775), CACNA1D(776), CACNA1F(778), CACNA1S(779) |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
¥ 3683.17
-
询价
-
询价
-
询价
-
询价
-
¥ 1310.31
-
询价
-
询价
-
询价
-
¥ 2067.03
-
¥ 1334.26
-
询价
-
¥ 1540.85
-
¥ 2005.84
-
¥ 852.85
-
¥ 381.67
-
¥ 2170.40
-
¥ 70526.15
-
¥ 3704.60
微信小程序
7X24小时在线咨询